Brief: Liminatus Pharma Announces Reverse Stock Split Of Its Common Stock
18/08/2026 21:09
BRIEF-Liminatus Pharma Announces Reverse Stock Split Of Its Common Stock Aug 18 (Reuters) - Liminatus Pharma Inc LIMN.O:
LIMINATUS PHARMA, INC. ANNOUNCES REVERSE STOCK SPLIT OF ITS COMMON STOCK
LIMINATUS PHARMA - ANNOUNCES 1-FOR-50 REVERSE STOCK SPLIT
LIMINATUS PHARMA - REVERSE STOCK SPLIT EFFECTIVE AUGUST 20, 2026; SPLIT-ADJUSTED TRADING BEGINS AUGUST 21, 2026
Source text: ID:nGNXDRLjm
Further company coverage: LIMN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminatus Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Liminatus Pharma Announces Reverse Stock Split Of Its Common Stock
Brief: Liminatus Pharma Announces Planned Phase 1 Clinical Trial Of Iba101, A Next-Generation Cd47 Blocking Antibody
Brief: Liminatus Pharma Enters Settlement Agreement With Clear Street LLC